The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 4991-4999

  Lee, Sarah Y ^a   Goverman, Joan M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; ECALECTIN; GAMMA INTERFERON; MUCIN 3;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; GENETIC ASSOCIATION; IN VIVO STUDY; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION;

EID: 84877800541     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300083     Document Type: Article

References (46)

1. Anderson, A. C., D. E. Anderson, L. Bregoli, W. D. Hastings, N. Kassam, C. Lei, R. Chandwaskar, J. Karman, E. W. Su, M. Hirashima, et al. 2007. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143. (Pubitemid 350134897)
2. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, et al. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541. (Pubitemid 34130609)
3. Joller, N., A. Peters, A. C. Anderson, and V. K. Kuchroo. 2012. Immune checkpoints in central nervous system autoimmunity. Immunol. Rev. 248: 122-139.
4. Zhu, C., A. C. Anderson, A. Schubart, H. B. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, and V. K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6: 1245-1252. (Pubitemid 43045636)
5. Chen, Y., C. L. Langrish, B. McKenzie, B. Joyce-Shaikh, J. S. Stumhofer, T. McClanahan, W. Blumenschein, T. Churakovsa, J. Low, L. Presta, et al. 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116: 1317-1326.
6. + T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 39: 2492-2501.
7. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
8. Sawcer, S., G. Hellenthal, M. Pirinen, C. C. Spencer, N. A. Patsopoulos, L. Moutsianas, A. Dilthey, Z. Su, C. Freeman, S. E. Hunt, et al International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
9. Koguchi, K., D. E. Anderson, L. Yang, K. C. O'Connor, V. K. Kuchroo, and D. A. Hafler. 2006. Dysregulated T cell expression of TIM3 in multiple sclerosis. J. Exp. Med. 203: 1413-1418. (Pubitemid 43877603)
10. Yang, L., D. E. Anderson, J. Kuchroo, and D. A. Hafler. 2008. Lack of TIM-3 immunoregulation in multiple sclerosis. J. Immunol. 180: 4409-4414.
11. Nociti, V., A. Cianfoni, M. Mirabella, M. Caggiula, G. Frisullo, A. K. Patanella, C. Sancricca, F. Angelucci, P. A. Tonali, and A. P. Batocchi. 2005. Clinical characteristics, course and prognosis of spinal multiple sclerosis. Spinal Cord 43: 731-734. (Pubitemid 41759827)
12. Stromnes, I. M., L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14: 337-342. (Pubitemid 351347910)
13. Zozulya, A. L., and H. Wiendl. 2008. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum. Immunol. 69: 797-804.
14. +) T cells in multiple sclerosis. Ann. Neurol. 66: 132-141.
15. Mars, L. T., P. Saikali, R. S. Liblau, and N. Arbour. 2011. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim. Biophys. Acta 1812: 151-161.
16. Gay, F. W., T. J. Drye, G. W. Dick, and M. M. Esiri. 1997. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: identification and characterization of the primary demyelinating lesion. Brain 120: 1461-1483.
17. +) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404. (Pubitemid 30629164)
18. Bitsch, A., J. Schuchardt, S. Bunkowski, T. Kuhlmann, and W. Bruck. 2000. Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 123: 1174-1183. (Pubitemid 30312109)
19. Neumann, H., I. M. Medana, J. Bauer, and H. Lassmann. 2002. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25: 313-319. (Pubitemid 34667013)
20. + T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125: 538-550. (Pubitemid 34194409)
21. + T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 101: 2428-2433. (Pubitemid 38269328)
22. Junker, A., J. Ivanidze, J. Malotka, I. Eiglmeier, H. Lassmann, H. Wekerle, E. Meinl, R. Hohlfeld, and K. Dornmair. 2007. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130: 2789-2799. (Pubitemid 350033964)
23. + T cells in murine acute graft-versus-host disease. J. Immunol. 177: 4281-4287. (Pubitemid 44469756)
24. Sehrawat, S., P. B. J. Reddy, N. Rajasagi, A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2010. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 6: e1000882.
25. + T cell dysfunction in melanoma patients. J. Exp. Med. 207: 2175-2186.
26. + T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 117: 4501-4510.
27. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
28. + T cells. J. Virol. 83: 9122-9130.
29. Jin, H. T., A. C. Anderson, W. G. Tan, E. E. West, S. J. Ha, K. Araki, G. J. Freeman, V. K. Kuchroo, and R. Ahmed. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107: 14733-14738.
30. + T cells by rapid induction of multiple inhibitory receptors. J. Immunol. 184: 4696-4707.
31. Sakuishi, K., L. Apetoh, J. M. Sullivan, B. R. Blazar, V. K. Kuchroo, and A. C. Anderson. 2010. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207: 2187-2194.
32. Almolda, B., B. Gonzalez, and B. Castellano. 2011. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front. Biosci. 16: 1157-1171.
33. Chastain, E. M., D. S. Duncan, J. M. Rodgers, and S. D. Miller. 2011. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta 1812: 265-274.
34. + monocytes. J. Leukoc. Biol. 91: 189-196.
35. + T cells maintain tolerance to myelin basic protein by 'epitope theft.' Nat. Immunol. 5: 606-614. (Pubitemid 38811885)
36. Abdul-Majid, K. B., J. Jirholt, C. Stadelmann, A. Stefferl, P. Kjellén, E. Wallstrom, R. Holmdahl, H. Lassmann, T. Olsson, and R. A. Harris. 2000. Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J. Neuroimmunol. 111: 23-33.
37. Stromnes, I. M., and J. M. Goverman. 2006. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1: 1810-1819. (Pubitemid 46773300)
38. + T cells expressing dual TCRs. Nat. Immunol. 11: 628-634.
39. Brabb, T., P. von Dassow, N. Ordonez, B. Schnabel, B. Duke, and J. Goverman. 2000. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192: 871-880.
40. + Tregs. J. Clin. Invest. 122: 2395-2404.
41. Sabatos, C. A., S. Chakravarti, E. Cha, A. Schubart, A. Sánchez-Fueyo, X. X. Zheng, A. J. Coyle, T. B. Strom, G. J. Freeman, and V. K. Kuchroo. 2003. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4: 1102-1110. (Pubitemid 37428038)
42. Yeung, M. Y., M. McGrath, and N. Najafian. 2011. The emerging role of the TIM molecules in transplantation. Am. J. Transplant. 11: 2012-2019.
43. Ngiow, S. F., B. von Scheidt, H. Akiba, H. Yagita, M. W. Teng, and M. J. Smyth. 2011. Anti-TIM3 antibody promotes T cell IFN-g-mediated antitumor immunity and suppresses established tumors. Cancer Res. 71: 3540-3551.
44. Rangachari, M., C. Zhu, K. Sakuishi, S. Xiao, J. Karman, A. Chen, M. Angin, A. Wakeham, E. A. Greenfield, R. A. Sobel, et al. 2012. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat. Med. 18: 1394-1400.
45. Popescu, B. F., and C. F. Lucchinetti. 2012. Pathology of demyelinating diseases. Annu. Rev. Pathol. 7: 185-217.
46. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334. (Pubitemid 40460562)